Multistate Generic Lawsuit Expands and Includes Executives
A multistate antitrust investigation on generic drug pricing has expanded further. It now includes suits against executives at generic makers. In late October, Connecticut Attorney
Home » Industry News » Page 3
A multistate antitrust investigation on generic drug pricing has expanded further. It now includes suits against executives at generic makers. In late October, Connecticut Attorney
The U.S. Food and Drug Administration on Monday announced a series of measures designed to speed to market generic versions of complex drugs such as
In April 2016, at the height of the deadliest drug epidemic in U.S. history, Congress effectively stripped the Drug Enforcement Administration of its most potent
A year ago, Maine was one of the first states to set limits on opioid prescriptions. The goal in capping the dose of prescription painkillers
It’s not the only answer, but it could be part of the solution to the deadliest drug crisis in US history. There’s another type of prescription
For the first time since being diagnosed 10 years ago, Krahne, 65, decided to delay filling his prescription, hoping that his cancer wouldn’t take advantage
Insurers, employers, unions and government programs are not required to hire a PBM. Instead the vast majority choose to do so because PBMs have a
PDMPs are state-run electronic databases designed to track prescribing of controlled substances and to identify people at high risk of using opioids for nonmedical purposes.
Lowcost Pharmacy Benefit Management
877.877.5711
info@arayarx.com
PO Box 460
Latham, NY 12110